It’s the season to go a little overboard on gift giving. But this year, give the gift of good security (and privacy) and eschew tech that can have untoward risks or repercussions. We’re no
When COVID-19 closed down most of society in 2020, Kian Sadeghi, like many of his then-classmates at the University of Pennsylvania, found himself holed up in his bedroom. He prefers it that way. Du
Oova officially launched its Oova Kit that includes an at-home test that quantitatively measures two hormones, informing a woman — and her doctor — of her fertile days and confirming ovulation.
Sano Genetics, a startup with a broad mission to support personalised medicine research by increasing participation in clinical trials, has raised £2.5 million in seed funding. The round is led by Ep
DNA testing technology company 23andMe has raised just shy of $82.5 million in new funding, from an offering of $85 million in total equity shares, according to a new SEC filing. The funding, confirme
A state senator in California is introducing legislation designed to provide more oversight over direct-to-consumer genetic testing companies. The new regulations, introduced by Santa Ana’s Demo
Excitement in the consumer genetic testing market continues to show signs of slowing down. In the past two weeks, layoffs have hit two of the biggest consumer genetic testing services — 23andme and
Precise.ly, the new genomics startup launched by 23andMe co-founder Linda Avey and Aneil Mallavarapu, is taking its spin on direct to consumer personalized genomics to India through a partnership with
Color, the genetics testing company, is partnering with Alphabet’s health technology-focused subsidiary, Verily Life Sciences, to provide to the company’s Baseline Health Study participant
The U.S. Department of Justice has issued a preliminary set of guidelines for how law enforcement agencies can use in their investigations genetic information from consumer DNA analysis services. “P
Probably Genetic hopes to provide families of children on the autism spectrum with more complete diagnoses.
Venture capitalists are pouring hundreds of millions of dollars into healthcare startups pitching lower-cost alternatives to traditional services, and one of their primary targets is diagnostics. As i
Welcome to the future… where startups are willing to customize everything from a diet regimen to a workout plan, or family planning to personal fashion based on an individual’s genetic c
Prenetics, a genetic testing startup, plans to expand into more Asian countries after raising a $40 million Series B led by Beyond Ventures and Alibaba Hong Kong Entrepreneurs Fund.
The company first began making moves early in 2015, forging a partnership with Pfizer to conduct a bit of drug research using 23andMe’s genetic data. The pact was formed in the midst of orders f
Cancer and heart disease are the two leading causes of death in the United States. So far, Color Genomics has been focused on testing for mutations leading to a higher risk of certain cancers. But, to
Genoox, a startup that wants to make it easier for medical professionals to use genomic data in patient care, has raised $6 million in funding. The capital includes a seed round from Inimiti Capital P
The Food and Drug Administration finally gave 23andMe a long sought-after green light today to sell to consumers genetic tests and their accompanying health risk reports for up to 10 diseases, includi
One of the first consumer genetic testing companies, 23andMe says it aims to be at the forefront in gathering genetically diverse data throughout the world. The company just launched a standalone $99
Want to know if you have the “athlete gene” or if you’re actually related to the weirdos who claim you as a family member? Get your collection tubes ready, citizen scientists, Bento
Load More